Heat therapy combined with immunotherapy for advanced liver cancer
Part of Cancer clinical trials.
This trial tests whether combining heat-based treatment of a tumor with immunotherapy drugs can help people with advanced liver cancer that cannot be surgically removed. The goal is to shrink tumors and improve survival by using the body's immune system alongside localized heat treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–80 years old
- Diagnosed with unresectable (cannot be surgically removed) liver cancer, stage B or C
- No prior chemotherapy, immunotherapy, or targeted drugs for liver cancer
- Have one treatable tumor lesion ≤5 cm (about 2 inches) that has never been treated before
- Liver function score (Child-Pugh) of 7 or lower, indicating stable liver disease
- Good overall health and ability to care for yourself (ECOG score 0–1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a heat-based treatment for liver cancer tumors that uses multiple methods to destroy cancer cells. It may help people with liver tumors that haven't spread and who are healthy enough for treatment.
This trial is testing a combination of treatments for liver cancer that cannot be removed by surgery. It combines a targeted therapy pill (lenvatinib), an immunotherapy that boosts your immune system (PD-1 blocker), a procedure that destroys tumors with heat or cold (ablation), and a chemo procedure that delivers medicine directly to the liver (TACE). The goal is to see if this mix is safe and effective.
This trial tests a new treatment that uses heat to target liver tumors and boost the immune system. It is for women with breast cancer that has spread to the liver who cannot have or do not want surgery.
This trial tests a new combination treatment that uses heat (ablation) and other therapies to destroy liver tumors. It's for people who cannot have surgery or choose not to, and whose tumor is a specific size.
This study is testing whether combining targeted therapy with immunotherapy can help people with advanced liver cancer that cannot be surgically removed. The goal is to see if this combination treatment is safe and effective.
This study tests if adding heat therapy (hyperthermia) to immunotherapy can help people with advanced stomach or colorectal cancer that has spread to the liver. It's for patients who have already tried other treatments and are looking for new options.
Hear when a new Unresectable Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.